trovafloxacin has been researched along with cyclopropylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foss, FW; Macdonald, TL; Sun, Q; Zhu, R | 2 |
2 other study(ies) available for trovafloxacin and cyclopropylamine
| Article | Year |
|---|---|
Mechanisms of trovafloxacin hepatotoxicity: studies of a model cyclopropylamine-containing system.
Topics: Aldehydes; Chromatography, Liquid; Cyclopropanes; Fluoroquinolones; Liver; Magnetic Resonance Spectroscopy; Models, Biological; Molecular Structure; Naphthyridines; Oxidation-Reduction | 2007 |
In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity.
Topics: Aldehydes; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cross-Linking Reagents; Cyclopropanes; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Fluoroquinolones; Humans; In Vitro Techniques; Liver; Microsomes, Liver; Naphthyridines; Oxidation-Reduction; Peroxidase; Procainamide; Riluzole | 2008 |